Comparison of the pre-treatment assessment of patients with post-molar gestational trophoblastic neoplasia in low-risk and high-risk complete hydatidiform mole groups
| Assessment index | Post-molar gestational trophoblastic neoplasia in low-risk complete hydatidiform mole group (n=23) | Post-molar gestational trophoblastic neoplasia in high-risk complete hydatidiform mole group (n=28) | Z value | P value |
| Interval from end of index pregnancy to treatment (days), median (Q25–Q75) | 47 (35–80) | 45.5 (37–66) | −0.199 | 0.842 |
| Pretreatment serum hCG (IU/L), median (Q25–Q75) | 1767 (275–14 342) | 4688 (1202–14 689) | −1.022 | 0.307 |
| FIGO anatomical stage (n) | −0.692 | 0.489 | ||
| I | 8 | 8 | ||
| II | 1 | 0 | ||
| III | 14 | 20 | ||
| FIGO score (n) | −1.896 | 0.058 | ||
| 0 | 7 | 2 | ||
| 1 | 8 | 9 | ||
| 2 | 2 | 9 | ||
| 3 | 6 | 5 | ||
| 4 | 0 | 1 | ||
| 5 | 0 | 2 |
FIGO, International Federation of Gynecology and Obstetrics.